Pivot Accelerates Development of CBD Products for Domestic Pet Market

Published: May 18, 2018

Pivot Accelerates Development of CBD Products for Domestic Pet Market

Pivot Pharmaceuticals Inc. has accelerated development of several cannabidiol (“CBD”) products for the domestic pet food market. Pivot will use its patented Ready-To-Infuse-Cannabis powder to manufacture and commercialize capsules and sachets to deliver bio-available CBD to pets. The Company will also develop and commercialize a line of pet creams using its Thrudermic Transdermal Nanotechnology. Pivot’s pet product line will be marketed under the brand “Pivot Naturals For Pets” and target indications such as joint pain, inflammation, post-surgical pain and skin disorders.

 

“With Pivot’s line of pet products, the pain-relieving effects of CBD can be delivered orally, topically or as an additive sprinkled on pet food,” said Dr. Joseph Borovksy, Pivot’s Executive Vice-President, Product Development, “Pivot’s technologies are versatile and allow us to develop and commercialize products for both the human and veterinary markets. Our suite of patented technologies will allow us to continually innovate and bring dozens of differentiated, value-added derivatives to market, where regulations permit, in Canada, U.S. and the EU.”